View Older Stories
-
The Food Fight is Over: TUMSĀ® Declares It is Time to Love Food Back
-
/C O R R E C T I O N -- GSK Consumer Healthcare/
-
Pre-Open Stock Movers 03/28: (KXIN) (HYMC) (TSLA) Higher; (BYND) (VIR) (MCHP) Lower (more...)
-
GSK more upbeat on profits and COVID, investors not sure
-
GSK rejects Elliott's demands for board change, consumer sale
-
GlaxoSmithKline taps Goldman, Citi to advise on consumer unit spinoff - Bloomberg News
-
GSK v. Teva 'Skinny Label' Ruling Positive for Amarin (AMRN) - Citi
-
Citi Resumes GlaxoSmithKline (GSK:LN) (GSK) at Neutral
-
As steep patent cliff looms, Shionogi moves to develop its own U.S. sales staff
-
Drugmaker GSK to split after striking Pfizer consumer health deal
-
GlaxoSmithKline (GSK) to Acquire TESARO (TSRO) for $5.1B
-
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
-
GlaxoSmithKline (GSK) Acquires Novartis' (NVS) 36.5% Stake in Consumer Healthcare Joint Venture for $13B
-
Exclusive: J&J out of race for Pfizer's $20 billion consumer unit as deadline looms
-
UPDATE: GlaxoSmithKline (GSK) Said Exploring Takeover of United Therapeutics (UTHR), Gilead (GILD) Seen as Front-runner - Standard
-
Dividends a worry at drugmakers Astra, GSK after dramatic week
-
Citi Downgrades GlaxoSmithKline (GSK) to Neutral
-
Top British American Tobacco investor Woodford says backs Reynolds deal
-
Complete Donald Trump Stock Impact Guide
-
Notable Analyst Rating Changes 7/14: (GSK) (RRC) (SO) Upgraded; (ATW) (BRCD) (INFO) Downgraded
-
Notable Analyst Rating Changes 7/1: (GSK) (WRI) (GEL) Upgraded; (CVRR) (SWKS) (AVY) Downgraded
-
Citi Upgrades GlaxoSmithKline (GSK) to Buy
-
Citi Upgrades GlaxoSmithKline (GSK) to Buy
-
Pre-Open Stock Movers 1/5: (CNAT) (STXS) (URZ) (CEMP) Higher; (BCLI) (OAS) (SNY) Lower (more...)
-
Pre-Open Stock Movers 12/18: (ZAGG) (OVAS) (TTPH) (RAD) Higher; (MLHR) (KEX) (BRKR) Lower (more
-
Notable Analyst Rating Changes 11/25: (TJX) (PBR) (UTX) Upgraded; (P) (CYBR) (NFLX) Downgraded
-
Notable Analyst Rating Changes 12/17: (HPQ) (FB) (WDC) Upgraded; (TWTR) (CENX) (HAE) Downgraded
-
Citi Downgrades GlaxoSmithKline (GSK) to Neutral
-
Notable Analyst Rating Changes 05/28: (GSK) (KSU) (MRK) Upgraded; (STJ) (FE) (VSAT) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 01/18: (NCLH) (AAPL) (COF) (C) (CVX)
-
Top 10 News Items 7/16-7/20: Bernanke Points to Slower Than Expected Growth; A Wave of Tech Earnings; Marissa Mayer Named New Yahoo! CEO
-
Pre-Open Winners 7/16: (PRX) (AUTH) (HGSI) Higher (more...)
-
Top 10 News Items 4/16-4/20: Earnings Season is in Full Swing; Apple Continues Giving Up Gains; Buffett Announces Prostate Cancer Diagnosis
-
Berkowitz's Fairholme Shows New Stake in Jefferies (JEF), Ups Stake In AIG (AIG), BofA (BAC), Citi (C); Liquidates Cisco (CSCO)
-
Notable Analyst Rating Changes 05/31: (GS) (NVDA) (TZOO) Upgraded; (GSK) (MDT) (TASR) Downgraded
-
Berkowitz's Fairholme Picks Up Pharma Stakes, and Cisco (CSCO); Swaps General Growth (GGP) for Brookfield (BAM)
-
Daily State of the Markets 01/11: Bulls, Bears (and Cubbies)
-
Citi Downgrades GlaxoSmithKline (GSK) to Hold
-
Top 10 News Items 11/15-11/19: The General (GM) Is Back!, China Raises Reserve Requirement for 5th Time This Year, 'Merger Monday' - Literally!
-
Citi Reiterates a 'Buy' on WPI, TEVA & MYL After Generic Approval of VALTREX
-
Morning Movers 5/11: RGDX, AGEN, RZ, MFB, LM Higher; PCLN, BEE, TIXC, BPZ, RCKY Lower
-
Morning Movers 9/17: HYTM, IVAN, XNPT, RNN, BSTC, AMR, SOLF Higher; DARA, SNV, HW Lower
-
Swine Flu Stocks Higher After China Becomes 1st Country To Issue Mass H1N1 Inoculation
-
Notable Analyst Rating Changes 6/11: RF, FITB, BBT, HBAN, STI, BAC, GSK Upgraded; UNH, TIN, ALV, VPRT Downgraded
-
Morning Movers 3/31: AMLN, TBSI, FUQI, TXT, STSI Higher; TLCV, ACOR, ALTH, OXM, HIG Lower
-
David Moenning's Daily State of the Markets: 3/18
-
Notable Analyst Rating Changes 3/17: TGT, HD, JPM Upgraded; LVS, MS, FSLR Downgraded
-
Notable Analyst Rating Changes 1/26: LEN, GRMN, LUV, PETM, LEAP Upgraded; BHP, BAC, USB, AFL, ENR Downgraded
-
Citi Downgrades XenoPort (XNPT) to Hold, Slashes Price Target
-
David Moenning's Daily State of the Markets: 11/24